Rajat Dhar1, Allyson R Zazulia, Colin P Derdeyn, Michael N Diringer. 1. 1Department of Neurology, Washington University School of Medicine, St. Louis, MO.2Department of Radiology, Washington University School of Medicine, St. Louis, MO.3Department of Neurosurgery, Washington University School of Medicine, St. Louis, MO.
Abstract
OBJECTIVES: Impaired oxygen delivery due to reduced cerebral blood flow is the hallmark of delayed cerebral ischemia following subarachnoid hemorrhage. Since anemia reduces arterial oxygen content, it further threatens oxygen delivery increasing the risk of cerebral infarction. Thus, subarachnoid hemorrhage may constitute an important exception to current restrictive transfusion practices, wherein raising hemoglobin could reduce the risk of ischemia in a critically hypoperfused organ. In this physiologic proof-of-principle study, we determined whether transfusion could augment cerebral oxygen delivery, particularly in vulnerable brain regions, across a broad range of hemoglobin values. DESIGN: Prospective study measuring cerebral blood flow and oxygen extraction fraction using O-PET. Vulnerable brain regions were defined as those with baseline oxygen delivery less than 4.5 mL/100 g/min. SETTING: PET facility located within the Neurology/Neurosurgery ICU. PATIENTS: Fifty-two patients at risk for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage with hemoglobin 7-13 g/dL. INTERVENTIONS: Transfusion of one unit of RBCs over 1 hour. MEASUREMENTS AND MAIN RESULTS: Baseline hemoglobin was 9.7 g/dL (range, 6.9-12.9), and cerebral blood flow was 43 ± 11 mL/100 g/min. After transfusion, hemoglobin rose from 9.6 ± 1.4 to 10.8 ± 1.4 g/dL (12%; p < 0.001) and oxygen delivery from 5.0 (interquartile range, 4.4-6.6) to 5.5 mL/100 g/min (interquartile range, 4.8-7.0) (10%; p = 0.001); the response was comparable across the range of hemoglobin values. In vulnerable brain regions, transfusion resulted in a greater (16%) rise in oxygen delivery associated with reduction in oxygen extraction fraction, independent of Hgb level (p = 0.002 vs normal regions). CONCLUSIONS: This study demonstrates that RBC transfusion improves cerebral oxygen delivery globally and particularly to vulnerable regions in subarachnoid hemorrhage patients at risk for delayed cerebral ischemia across a wide range of hemoglobin values and suggests that restrictive transfusion practices may not be appropriate in this population. Large prospective trials are necessary to determine if these physiologic benefits translate into clinical improvement and outweigh the risk of transfusion.
OBJECTIVES: Impaired oxygen delivery due to reduced cerebral blood flow is the hallmark of delayed cerebral ischemia following subarachnoid hemorrhage. Since anemia reduces arterial oxygen content, it further threatens oxygen delivery increasing the risk of cerebral infarction. Thus, subarachnoid hemorrhage may constitute an important exception to current restrictive transfusion practices, wherein raising hemoglobin could reduce the risk of ischemia in a critically hypoperfused organ. In this physiologic proof-of-principle study, we determined whether transfusion could augment cerebral oxygen delivery, particularly in vulnerable brain regions, across a broad range of hemoglobin values. DESIGN: Prospective study measuring cerebral blood flow and oxygen extraction fraction using O-PET. Vulnerable brain regions were defined as those with baseline oxygen delivery less than 4.5 mL/100 g/min. SETTING: PET facility located within the Neurology/Neurosurgery ICU. PATIENTS: Fifty-two patients at risk for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage with hemoglobin 7-13 g/dL. INTERVENTIONS: Transfusion of one unit of RBCs over 1 hour. MEASUREMENTS AND MAIN RESULTS: Baseline hemoglobin was 9.7 g/dL (range, 6.9-12.9), and cerebral blood flow was 43 ± 11 mL/100 g/min. After transfusion, hemoglobin rose from 9.6 ± 1.4 to 10.8 ± 1.4 g/dL (12%; p < 0.001) and oxygen delivery from 5.0 (interquartile range, 4.4-6.6) to 5.5 mL/100 g/min (interquartile range, 4.8-7.0) (10%; p = 0.001); the response was comparable across the range of hemoglobin values. In vulnerable brain regions, transfusion resulted in a greater (16%) rise in oxygen delivery associated with reduction in oxygen extraction fraction, independent of Hgb level (p = 0.002 vs normal regions). CONCLUSIONS: This study demonstrates that RBC transfusion improves cerebral oxygen delivery globally and particularly to vulnerable regions in subarachnoid hemorrhagepatients at risk for delayed cerebral ischemia across a wide range of hemoglobin values and suggests that restrictive transfusion practices may not be appropriate in this population. Large prospective trials are necessary to determine if these physiologic benefits translate into clinical improvement and outweigh the risk of transfusion.
Authors: Jeffrey L Carson; Michael L Terrin; Helaine Noveck; David W Sanders; Bernard R Chaitman; George G Rhoads; George Nemo; Karen Dragert; Lauren Beaupre; Kevin Hildebrand; William Macaulay; Courtland Lewis; Donald Richard Cook; Gwendolyn Dobbin; Khwaja J Zakriya; Fred S Apple; Rebecca A Horney; Jay Magaziner Journal: N Engl J Med Date: 2011-12-14 Impact factor: 91.245
Authors: Emir Festic; Alejandro A Rabinstein; William D Freeman; Elizabeth A Mauricio; Maisha T Robinson; Jay Mandrekar; Abba C Zubair; Augustine S Lee; Ognjen Gajic Journal: Neurocrit Care Date: 2013-04 Impact factor: 3.210
Authors: Santiago Ramón Leal-Noval; María Dolores Rincón-Ferrari; Ana Marin-Niebla; Aurelio Cayuela; Victoria Arellano-Orden; Antonio Marín-Caballos; Rosario Amaya-Villar; Carmen Ferrándiz-Millón; Francisco Murillo-Cabeza Journal: Intensive Care Med Date: 2006-09-22 Impact factor: 17.440
Authors: Lars B Holst; Nicolai Haase; Jørn Wetterslev; Jan Wernerman; Anne B Guttormsen; Sari Karlsson; Pär I Johansson; Anders Aneman; Marianne L Vang; Robert Winding; Lars Nebrich; Helle L Nibro; Bodil S Rasmussen; Johnny R M Lauridsen; Jane S Nielsen; Anders Oldner; Ville Pettilä; Maria B Cronhjort; Lasse H Andersen; Ulf G Pedersen; Nanna Reiter; Jørgen Wiis; Jonathan O White; Lene Russell; Klaus J Thornberg; Peter B Hjortrup; Rasmus G Müller; Morten H Møller; Morten Steensen; Inga Tjäder; Kristina Kilsand; Suzanne Odeberg-Wernerman; Brit Sjøbø; Helle Bundgaard; Maria A Thyø; David Lodahl; Rikke Mærkedahl; Carsten Albeck; Dorte Illum; Mary Kruse; Per Winkel; Anders Perner Journal: N Engl J Med Date: 2014-10-01 Impact factor: 91.245
Authors: Sarah C Jost; Michael N Diringer; Allyson R Zazulia; Tom O Videen; Venkatesh Aiyagari; Robert L Grubb; William J Powers Journal: J Neurosurg Date: 2005-07 Impact factor: 5.115
Authors: Andrew M Naidech; Ali Shaibani; Rajeev K Garg; Isis M Duran; Storm M Liebling; Sarice L Bassin; Bernard R Bendok; Richard A Bernstein; H Hunt Batjer; Mark J Alberts Journal: Neurocrit Care Date: 2010-12 Impact factor: 3.210
Authors: David J Roh; David J Albers; Jessica Magid-Bernstein; Kevin Doyle; Eldad Hod; Andrew Eisenberger; Santosh Murthy; Jens Witsch; Soojin Park; Sachin Agarwal; E Sander Connolly; Mitchell S V Elkind; Jan Claassen Journal: Neurology Date: 2019-06-17 Impact factor: 9.910
Authors: Meher R Juttukonda; Chelsea A Lee; Niral J Patel; Larry T Davis; Spencer L Waddle; Melissa C Gindville; Sumit Pruthi; Adetola A Kassim; Michael R DeBaun; Manus J Donahue; Lori C Jordan Journal: J Magn Reson Imaging Date: 2018-10-15 Impact factor: 4.813
Authors: Melanie E Fields; Amy E Mirro; Michael M Binkley; Kristin P Guilliams; Josiah B Lewis; Slim Fellah; Yasheng Chen; Monica L Hulbert; Hongyu An; Andria L Ford; Jin-Moo Lee Journal: Am J Hematol Date: 2022-02-14 Impact factor: 13.265
Authors: Elke Schmitt; Patrick Meybohm; Vanessa Neef; Peter Baumgarten; Alexandra Bayer; Suma Choorapoikayil; Patrick Friederich; Jens Friedrich; Christof Geisen; Erdem Güresir; Matthias Grünewald; Martin Gutjahr; Philipp Helmer; Eva Herrmann; Markus Müller; Diana Narita; Ansgar Raadts; Klaus Schwendner; Erhard Seifried; Patrick Stark; Andrea U Steinbicker; Josef Thoma; Markus Velten; Henry Weigt; Christoph Wiesenack; Maria Wittmann; Kai Zacharowski; Florian Piekarski Journal: Acta Neurochir (Wien) Date: 2022-02-26 Impact factor: 2.216
Authors: Sean N Neifert; Emily K Chapman; Michael L Martini; William H Shuman; Alexander J Schupper; Eric K Oermann; J Mocco; R Loch Macdonald Journal: Transl Stroke Res Date: 2020-10-19 Impact factor: 6.829